Skip to content

Bandage Contact Lens Application for the Management of Corneal Abrasion

Bandage Contact Lens Application for the Management of Corneal Abrasion in the Emergency Department

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04159714
Enrollment
1
Registered
2019-11-12
Start date
2019-09-10
Completion date
2019-10-24
Last updated
2023-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Abrasion

Brief summary

The researchers are trying to understand if the application of a bandage contact lens results in better relief than usual treatment for a corneal abrasion.

Interventions

DEVICEAir Optix contact lens

Contact lens will be placed on the surface of the patient's eye and is to be used as a bandage

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Superficial Corneal Abrasion

Exclusion criteria

* Incarceration * Pregnancy * Inability to Provide Informed Consent * Infectious keratitis * Retained foreign bodies in the eye * Active infection involving the orbit or periorbital region * Patients who are not able to or who are deemed unlikely to follow-up with ophthalmology * A history or recent contact lens wear * A lack of trauma or an unclear history of trauma as the inciting cause of the abrasion * Allergy to the antimicrobial solution (POLYTRIM) * Women who are currently breastfeeding * Chronic eye drop use * A history of eye surgery other than cataract surgery (greater than 6 months prior to abrasion) * Diabetes (Patients with even mild diabetic neuropathy can have decreased pain sensation and also delayed corneal epithelial healing) * Any eye condition that may be deemed to interfere with the conduct of the protocol or outcome measurement.

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain ScoreBaseline, approx. 12-24 hours, approx. 36-48 hours, approx. 1 day, 3 days, and/or 5 days post-dischargeMeasured on scale of 0 being no pain, 5 being moderate pain and 10 being worst pain possible

Countries

United States

Participant flow

Participants by arm

ArmCount
Bandage Contact Lens (BCL) Group
Subjects diagnosed with superficial corneal abrasion in the Emergency Department will have a bandage contact lens soaked in antibiotic solution placed in the affected eye Air Optix contact lens: Contact lens will be placed on the surface of the patient's eye and is to be used as a bandage
1
Usual Care Group
Subjects diagnosed with superficial corneal abrasion in the Emergency Department will have usual care provided in the Emergency Department
0
Total1

Baseline characteristics

CharacteristicBandage Contact Lens (BCL) GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
1 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants
Region of Enrollment
United States
1 participants1 participants
Sex: Female, Male
Female
0 Participants0 Participants
Sex: Female, Male
Male
1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 10 / 0
other
Total, other adverse events
0 / 10 / 0
serious
Total, serious adverse events
0 / 10 / 0

Outcome results

Primary

Change in Pain Score

Measured on scale of 0 being no pain, 5 being moderate pain and 10 being worst pain possible

Time frame: Baseline, approx. 12-24 hours, approx. 36-48 hours, approx. 1 day, 3 days, and/or 5 days post-discharge

Population: Study terminated due to change in practice decreasing availability of eligible patients. Data was not collected or analyzed.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026